Evoke Pharma Inc Quarterly Return On Equity in % from Q2 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Evoke Pharma Inc quarterly/annual Return On Equity history and growth rate from Q2 2014 to Q3 2024.
  • Evoke Pharma Inc Return On Equity for the quarter ending September 30, 2024 was -309 %, a 40.4% increase year-over-year.
  • Evoke Pharma Inc annual Return On Equity for 2023 was 3.95K %.
  • Evoke Pharma Inc annual Return On Equity for 2022 was -176 %, a 13.6% decline from 2021.
  • Evoke Pharma Inc annual Return On Equity for 2021 was -155 %, a 108% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -309 +209 +40.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -964 -706 -273% Apr 1, 2024 Jun 30, 2024
Q1 2024 -4.9K -4.72K -2695% Jan 1, 2024 Mar 31, 2024
Q4 2023 3.95K +4.13K Oct 1, 2023 Dec 31, 2023
Q3 2023 -518 -340 -191% Jul 1, 2023 Sep 30, 2023
Q2 2023 -258 -73.7 -40% Apr 1, 2023 Jun 30, 2023
Q1 2023 -175 +24.6 +12.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -176 -21 -13.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -178 +60.5 +25.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -184 +246 +57.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -200 +2.23K +91.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -155 -2.19K -108% Oct 1, 2021 Dec 31, 2021
Q3 2021 -238 +745 +75.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -430 -40.1 -10.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -2.43K -2.28K -1545% Jan 1, 2021 Mar 31, 2021
Q4 2020 2.03K +2.18K Oct 1, 2020 Dec 31, 2020
Q3 2020 -983 -823 -513% Jul 1, 2020 Sep 30, 2020
Q2 2020 -390 -234 -150% Apr 1, 2020 Jun 30, 2020
Q1 2020 -148 +21.3 +12.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -150 +7.56 +4.79% Oct 1, 2019 Dec 31, 2019
Q3 2019 -160 -19.3 -13.6% Jul 1, 2019 Sep 30, 2019
Q2 2019 -156 +125 +44.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -169 +69.2 +29.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -158 +101 +39% Oct 1, 2018 Dec 31, 2018
Q3 2018 -141 +121 +46.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -282 -87.9 -45.4% Apr 1, 2018 Jun 30, 2018
Q1 2018 -238 +99.5 +29.5% Jan 1, 2018 Mar 31, 2018
Q4 2017 -258 +298 +53.6% Oct 1, 2017 Dec 31, 2017
Q3 2017 -262 +379 +59.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 -194 +384 +66.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 -338 +4.11 +1.2% Jan 1, 2017 Mar 31, 2017
Q4 2016 -557 -308 -124% Oct 1, 2016 Dec 31, 2016
Q3 2016 -640 -444 -225% Jul 1, 2016 Sep 30, 2016
Q2 2016 -578 -407 -238% Apr 1, 2016 Jun 30, 2016
Q1 2016 -342 -212 -163% Jan 1, 2016 Mar 31, 2016
Q4 2015 -248 -151 -155% Oct 1, 2015 Dec 31, 2015
Q3 2015 -197 -125 -174% Jul 1, 2015 Sep 30, 2015
Q2 2015 -171 -124 -267% Apr 1, 2015 Jun 30, 2015
Q1 2015 -130 Jan 1, 2015 Mar 31, 2015
Q4 2014 -97.2 Oct 1, 2014 Dec 31, 2014
Q3 2014 -71.9 Jul 1, 2014 Sep 30, 2014
Q2 2014 -46.5 Apr 1, 2014 Jun 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.